May 17, 2022 Comments Off on New patent for Janssen Pharms drug INVEGA HAFYERA Posted in: Patent Added Annual Drug Patent Expirations for INVEGA+HAFYERA Invega Hafyera is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Janssen Pharms drug INVEGA HAFYERA appe…
May 17, 2022 Comments Off on New patent for Millicent drug INTRAROSA Posted in: Patent Added Annual Drug Patent Expirations for INTRAROSA Intrarosa is a drug marketed by Millicent and is included in one NDA. There are three patents protecting this drug. INTRAROSA drug price trends.…
The post New patent for Millicent drug INTRAROSA appeared fir…
